Does Preoperative Symptom Duration Impact Clinical Outcomes After Minimally Invasive Transforaminal Lumbar Interbody Fusion in the Ambulatory Setting?

James W Nie; Timothy J Hartman; Keith R MacGregor; Omolabake O Oyetayo; Eileen Zheng; Kern Singh

doi:10.1016/j.wneu.2022.07.055

Does Preoperative Symptom Duration Impact Clinical Outcomes After Minimally Invasive Transforaminal Lumbar Interbody Fusion in the Ambulatory Setting?

World Neurosurg. 2022 Oct:166:e599-e606. doi: 10.1016/j.wneu.2022.07.055. Epub 2022 Jul 19.

Authors

James W Nie¹, Timothy J Hartman¹, Keith R MacGregor¹, Omolabake O Oyetayo¹, Eileen Zheng¹, Kern Singh²

Affiliations

¹ Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois, USA.
² Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois, USA. Electronic address: kern.singh@rushortho.com.

PMID: 35863643
DOI: 10.1016/j.wneu.2022.07.055

Abstract

Background: The effect of prolonged symptom duration in patients undergoing ambulatory MIS-TLIF on postoperative clinical outcomes has not been well studied. We aim to compare symptom duration of pain and/or weakness on postoperative outcomes in patients undergoing outpatient MIS-TLIF.

Methods: Patients undergoing outpatient MIS-TLIF were gathered in a single-surgeon database. Exclusion criteria were patients missing onset of symptoms, date of surgery, or diagnosis of malignancy, trauma, or infection. Patients were grouped by symptoms <1 year or symptoms ≥1 year. Propensity score matching for demographics was utilized. Minimal clinically important difference (MCID) achievement was calculated by comparing change in patient-reported outcome measures (PROMs) to previously established values. Inferential statistics for demographics, perioperative characteristics, PROMs, and MCID were utilized to compare between groups and/or postoperative improvement.

Results: After matching, there were a total of 56 patients, with 30 patients with symptoms <1-year. The <1-year cohort reported significant improvement in all time points in VAS back/leg and 12-week/6-months in ODI. The ≥1-year cohort demonstrated significant improvement in 6-month Patient-Reported Outcomes Measurement-Information System Physical Function, 6-week to 1-year VAS back, 6-week VAS leg, and 6-month ODI. The <1-year cohort had higher MCID attainment rates in 1-year VAS back/leg.

Conclusions: Independent of symptom duration, patients reported significant improvement in back pain at all postoperative periods. Patients presenting with shorter symptom duration consistently reported significant improvement in leg pain postoperatively. Patients with shorter symptom duration demonstrated greater MCID achievement in back and leg pain. Patients indicated for outpatient MIS-TLIF may benefit more from earlier intervention following onset of symptoms.

Keywords: Ambulatory; Inpatient; MCID; MIS-TLIF; Outpatient; PROMs; Transforaminal Lumbar Interbody Fusion.

MeSH terms

Back Pain / etiology
Back Pain / surgery
Humans
Lumbar Vertebrae / surgery
Minimally Invasive Surgical Procedures
Spinal Fusion* / adverse effects
Treatment Outcome